A 62‑year‑old woman with type 2 diabetes is being followed in a value‑based care program. She uses a continuous glucose monitor (CGM) that provides detailed glucose data, which she electronically shares with her care team.
At her follow‑up visit, her provider notes that her most recent laboratory A1c is unavailable due to a missed lab draw. However, her CGM report shows a Glucose Management Indicator (GMI) of 7.2%. The care team wants to ensure her glycemic status is captured for quality reporting under updated HEDIS® measures.
Which statement best reflects how her glycemic control can be documented?
- A. GMI from CGM data can be used in place of hemoglobin A1c for quality reporting.
- B. GMI is useful for patient education but cannot be used for official quality measures.
- C. GMI should only be used if time‑in‑range data are also reported.
- D. GMI is not recognized by HEDIS® and must be converted to estimated A1c.
Want to Learn More about this Question?
Join Marie Frazzitta on Sept. 30th for the FREE
Ready or Not, Digital Quality Reporting Is Here: Diabetes Professionals are Poised to Lead the Transformation Webinar
Did you know that YOU are practicing in a healthcare system where the traditional fee for service model is giving way to value-based diabetes care, and how essential YOU are in that shift?
As a diabetes professional, you will want to keep up to date on this upheaval of traditional models of care. You have the opportunity to take a leadership role and demonstrate your worth.
Healthcare is changing, and it is changing quickly. Terms like digital quality measures (dQMs), HEDIS®, STAR Ratings, interoperability, value-based contracting, artificial intelligence, and digital health technology are appearing more frequently in healthcare conversations.
